Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6 Glioblastoma 4 Urinary Bladder Neoplasms 3 Colorectal Neoplasms 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Glioma 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1 Stomach Neoplasms 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphoma, Follicular 1 Lymphedema 1 Lung Injury 1

Interventions

Nivolumab 130 Sunitinib 120 pembrolizumab 116 Sorafenib 75 Everolimus 67 cabozantinib 66 Bevacizumab 66 pazopanib 60 Ipilimumab 55 Axitinib 55 aldesleukin 48 Magnetic Resonance Spectroscopy 41 Cyclophosphamide 36 Interleukin-2 33 Radiosurgery 32 Interferon-alpha 32 lenvatinib 31 Specimen Handling 29 temsirolimus 27 atezolizumab 24 belzutifan 21 fludarabine phosphate 20 Gemcitabine 20 avelumab 18 Radiotherapy 18 Interferon alpha-2 17 Biopsy 16 fludarabine 15 durvalumab 15 Paclitaxel 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01967407 2014-11-19

IRENE

University of Magdeburg

Phase 1/2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡